TNF-alpha-mediated Apoptosis in Chondrocytes Sensitized by MG132 or Actinomycin D
Overview
Authors
Affiliations
The mechanism of TNF-alpha-mediated chondrocyte apoptosis in human articular cartilage was investigated. First passage OA chondrocytes were treated with actinomycin D or MG132 in combination with TNF-alpha to facilitate cell death. The patterns of apoptosis-related proteins, NF-kappaB activation, and IkappaB degradation were analyzed. Cell death was increased by 0.2 microg/ml of actinomycin D or 20 microM MG132 in combination with TNF-alpha. Apoptosis potentiated by MG132 was more effectively inhibited by caspase inhibitors than that by actinomycin D. MG132 or actinomycin D both led to a significant increase in p53, but the expressions of the p53 response proteins increased only in MG132 treated chondrocytes. TNF-alpha induced chondrocyte IkappaB phosphorylation was unaffected by either MG132 or actinomycin D. MG132, but not actinomycin D, inhibited the chondrocyte IkappaB degradation induced by TNF-alpha and NF-kappaB activation. Our results suggest that MG132 and actinomycin D exert different influences upon TNF-alpha-mediated chondrocyte apoptotic signaling.
Wu C, Chou W, Jou I, Tu Y, Ma C, Tsai K J Orthop Surg Res. 2025; 20(1):206.
PMID: 40011998 PMC: 11866722. DOI: 10.1186/s13018-025-05602-9.
Xiong X, Liu L, Xu F, Wu X, Yin Z, Dong Y ACS Omega. 2021; 6(11):7638-7645.
PMID: 33778274 PMC: 7992146. DOI: 10.1021/acsomega.0c06212.
Yuan Z, Yuan Z, Hasnat M, Zhang H, Liang P, Sun L Acta Pharm Sin B. 2020; 10(5):861-877.
PMID: 32528833 PMC: 7280150. DOI: 10.1016/j.apsb.2020.02.009.
Thomas C, Whittles C, Fuller C, Sharif M Rheumatol Int. 2010; 31(10):1341-8.
PMID: 20396889 DOI: 10.1007/s00296-010-1471-9.
The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death.
Kim H, Lee K, Bae S Arthritis Res Ther. 2005; 7(3):R526-35.
PMID: 15899039 PMC: 1174948. DOI: 10.1186/ar1705.